Swiss

NDA Partners Appoints Senior Global Regulatory Affairs Executive, Dr. Daniela Drago as Partner in the Firm

Retrieved on: 
Tuesday, April 4, 2023
CSL Vifor, RAPS, Medical school, Swiss Federal Institute of Technology, Swiss, Biozentrum University of Basel, University, Gene, Swiss Federal Institute of Aquatic Science and Technology, ETH, Biogen, CMC, Roche, George Washington University Hospital, Bausch, Regulatory science, History, Doctor of Philosophy, Associate, Bausch & Lomb, ECPM, MS, FRAPS, Partner, UCSF, Ophthalmology, School, Cell, Executive Committee, Drug development, American Society of Gene and Cell Therapy, University of Messina, Regulatory affairs, George Washington University, Neurology, Pharmaceutical medicine, Society, Pharmaceutical industry, Medicine, Chemistry

WASHINGTON, April 4, 2023 /PRNewswire-PRWeb/ -- NDA Partners' Vice President and General Manager, Eric Fish, announced today that Dr. Daniela Drago, a senior global regulatory affairs executive, has been appointed as Partner in the firm. Dr. Drago first worked as an Expert Consultant with NDA Partners in 2014 and formerly held senior global regulatory and medical affairs positions at Biogen, Roche, Vifor Pharma, Reckitt Benckiser, Aurion Biotech, and Bausch & Lomb.

Key Points: 
  • NDA Partners' Vice President and General Manager, Eric Fish, announced today that Dr. Daniela Drago, a senior global regulatory affairs executive, has been appointed as Partner in the firm.
  • Dr. Drago first worked as an Expert Consultant with NDA Partners in 2014 and formerly held senior global regulatory and medical affairs positions at Biogen, Roche, Vifor Pharma, Reckitt Benckiser, Aurion Biotech, and Bausch & Lomb.
  • WASHINGTON, April 4, 2023 /PRNewswire-PRWeb/ -- NDA Partners' Vice President and General Manager, Eric Fish, announced today that Dr. Daniela Drago , a senior global regulatory affairs executive, has been appointed as Partner in the firm.
  • Dr. Drago is a CMC and global regulatory affairs executive with a history of accomplishments spanning pharmaceutical, biotech, and academic roles.

Rapyuta Robotics, Maker of the Pick-Assist Robot, Launches "Put-to-Light" Function to Reduce Picking Errors, Increase Productivity

Retrieved on: 
Thursday, March 16, 2023
Software, Supply Chain Management, Mobile, Wireless, Networks, Hardware, Electronic Design Automation, Data Management, Apps, Applications, Technology, Artificial Intelligence, Retail, Other Technology, Cloud, Robotics, Multimedia, CFO, ETH Zurich, LED, Peter Hancock (professor), Swiss Federal Institute of Technology, Light-emitting diode, Federal Institute of Science and Technology, Human, Swiss, Rapyuta, Blog, Computer data storage, Warehouse, GitHub, Cloud robotics

Rapyuta Robotics, Co., Ltd., the leading developer of collaborative pick-assist warehouse robots, and the pioneer in Cloud Robotics, will introduce its new “Put-to-Light” function on the Rapyuta PA-AMR to reduce picking errors and increase productivity, in Chicago March 20-23 at PROMAT.

Key Points: 
  • Rapyuta Robotics, Co., Ltd., the leading developer of collaborative pick-assist warehouse robots, and the pioneer in Cloud Robotics, will introduce its new “Put-to-Light” function on the Rapyuta PA-AMR to reduce picking errors and increase productivity, in Chicago March 20-23 at PROMAT.
  • For an in-person demo, visit Rapyuta Robotics at PROMATE 2023, booth #S5177, 2301 S. Lake Shore Drive, Chicago, Illinois, from March 20-23.
  • For how-to videos and insights about robotic solutions, follow Rapyuta Robotics on our blog , LinkedIn , Twitter , Facebook , and Github channels.
  • Rapyuta Robotics is a leading provider of flexible and collaborative autonomous mobile robot solutions, including their flagship product, Rapyuta PA-AMR.

Fengate closes on battery energy storage development partnership with Alpha Omega Power

Retrieved on: 
Wednesday, March 15, 2023
Retirement, Swiss Re, Credit Suisse, Wind, Partnership, United, Fengate, Peterborough, Merrill (company), AOP, Infrastructure Investment and Jobs Act, Swiss, Eastern Canada, BESS, Enron, Cryptocurrency, Renewable energy

HOUSTON, March 15, 2023 (GLOBE NEWSWIRE) -- Fengate Asset Management (“Fengate”) is pleased to announce financial close on a new development partnership with Alpha Omega Power (“AOP”) with the purpose of building a market-leading U.S. battery energy storage system (“BESS”) development platform.

Key Points: 
  • HOUSTON, March 15, 2023 (GLOBE NEWSWIRE) -- Fengate Asset Management (“Fengate”) is pleased to announce financial close on a new development partnership with Alpha Omega Power (“AOP”) with the purpose of building a market-leading U.S. battery energy storage system (“BESS”) development platform.
  • Fengate’s new development partner, AOP, is led by Paul Choi who brings more than 25 years of experience and a successful track record as a leader in power and renewable energy.
  • Most recently, Paul was the executive vice president of origination at Broad Reach Power where he built and led the origination team.
  • There is increasing demand for BESS projects due to the increasing supply of intermittent renewable energy projects and retirement of thermal power projects.

EQS-News: TVM Capital Life Science Announces Promotions to Recognize Significant Contributions of Up-and-Coming Leaders

Retrieved on: 
Thursday, February 23, 2023
Molecular biology, Doctor of Philosophy, University, Zurich Insurance Group, TVM, POLIMI Graduate School of Management, MBA, Partnership, IND, Alan Catello Grazioso, Investment, ETH Zurich, Federal Institute of Science and Technology, Economics, ITN, Therapy, Master of Science, Swiss, Investment banking, University of Milano-Bicocca, Pharmaceutical industry, Management

We are delighted to recognize the contributions Valentina, Catello and Philipp have made to the Company as well as their achievements with these well-deserved promotions.

Key Points: 
  • We are delighted to recognize the contributions Valentina, Catello and Philipp have made to the Company as well as their achievements with these well-deserved promotions.
  • It is gratifying to see each of them expand their roles in our team and take on increased responsibilities,“ said Dr. Luc Marengère, Managing Partner at TVM Capital Life Science.
  • Dr. Hubert Birner, Managing Partner at TVM Capital Life Science, added: “These promotions underscore TVM’s commitment to professional development and talent recognition.
  • Growing the next generation of leaders is an integral part of our strategy to position TVM for continued success.

TVM Capital Life Science Announces Promotions to Recognize Significant Contributions of Up-and-Coming Leaders

Retrieved on: 
Thursday, February 23, 2023
Molecular biology, Doctor of Philosophy, University, Zurich Insurance Group, TVM, POLIMI Graduate School of Management, MBA, Partnership, IND, Alan Catello Grazioso, Investment, ETH Zurich, Federal Institute of Science and Technology, Economics, ITN, Therapy, Master of Science, Swiss, Investment banking, University of Milano-Bicocca, Management, Pharmaceutical industry

We are delighted to recognize the contributions Valentina, Catello and Philipp have made to the Company as well as their achievements with these well-deserved promotions.

Key Points: 
  • We are delighted to recognize the contributions Valentina, Catello and Philipp have made to the Company as well as their achievements with these well-deserved promotions.
  • It is gratifying to see each of them expand their roles in our team and take on increased responsibilities,” said Dr. Luc Marengère, Managing Partner at TVM Capital Life Science.
  • Dr. Hubert Birner, Managing Partner at TVM Capital Life Science, added: “These promotions underscore TVM’s commitment to professional development and talent recognition.
  • Growing the next generation of leaders is an integral part of our strategy to position TVM for continued success.

Thierry Léger is appointed Chief Executive Officer of SCOR

Retrieved on: 
Thursday, January 26, 2023
Swiss Federal Institute of Technology, Executive Committee, Policy, Insurance, Risk management, Ponts, ISFA, Transformation, Q4, Mass meeting, Life, SCOR, P&C, Directorate-General for Economic and Financial Affairs, FFSA, Swiss Federal Institute of Aquatic Science and Technology, History, Swiss Re, Corporate finance, Civil engineering, ETH, Deutsche Bank, Lehman Brothers, Interim, Merrill (company), Supply chain operations reference, Environment, Institut des sciences de l'ingénieur de Toulon et du Var, Growth, Committee, University, Doctor of Philosophy, Engineering, Management, Investment, Swiss

The Board of Directors, acting on the proposal of the Nomination Committee, has unanimously decided to appoint Thierry Léger Chief Executive Officer of SCOR.

Key Points: 
  • The Board of Directors, acting on the proposal of the Nomination Committee, has unanimously decided to appoint Thierry Léger Chief Executive Officer of SCOR.
  • François de Varenne, Executive Committee member in charge of Investments, Technology, Transformation and Group Corporate Finance, is appointed Interim CEO of SCOR with immediate effect until Thierry Léger takes up his post.
  • As of January 2016, he was appointed Chief Executive Officer Life Capital and member of the Swiss Re Executive Committee.
  • In October 2008, he was appointed Chief Executive Officer of SCOR Global Investments.

ASMALLWORLD signs The Chedi Andermatt as first hotel of ASMALLWORLD DISCOVERY

Retrieved on: 
Thursday, February 2, 2023
ASMALLWORLD, Heart, Wine, Forbes Travel Guide, Partnership, Swiss, GHA, Swiss Alpine Museum, Acquisition, USD, Restaurant, Collection, Global Hotel Alliance, Nightclub, Hotel

Zurich, 23.01.2023 – Today, ASMALLWORLD AG announced that it has signed the prestigious The Chedi Andermatt as the first hotel of its newly-created ASMALLWORLD DISCOVERY soft brand, which allows independent hotels to join the GHA DISCOVERY loyalty platform with over 21 million customers.

Key Points: 
  • Zurich, 23.01.2023 – Today, ASMALLWORLD AG announced that it has signed the prestigious The Chedi Andermatt as the first hotel of its newly-created ASMALLWORLD DISCOVERY soft brand, which allows independent hotels to join the GHA DISCOVERY loyalty platform with over 21 million customers.
  • In May 2022, ASMALLWORLD completed the acquisition of a 10% stake in Global Hotel Alliance (GHA), a company that unites 40 hotel brands and more than 800 hotels in one shared loyalty programme called GHA DISCOVERY.
  • To support GHA with the expansion of its hotel portfolio, ASMALLWORLD’s newly created ASMALLWORLD DISCOVERY soft brand will soon be added to the 40 existing GHA DISCOVERY hotel brands.
  • In conjuntion with joining GHA DISCOVERY, The Chedi Andermatt will also become part of the prestigious Ultratravel Collection, a distinction reserved for DISCOVERY hotels of the highest standard.

EQS-News: BB BIOTECH AG: Molecular strike force for the immune system

Retrieved on: 
Sunday, December 18, 2022
Federal Institute for Drugs and Medical Devices, Autoimmune disease, Mast cell, Coagulopathy, Hives, Diagnosis, Quality of life, Clinical trial, Degenerative disease, Myasthenia gravis, Biochemistry, Portfolio manager, B cell, MS, Antibody, Cytokine, Immunoglobulin E, Allergy, Muscle weakness, Neuromuscular disease, Autoimmunity, Cancer, Kezar Stadium, Biotechnology, Dermatomyositis, UBS, Tablet, CDX, Angioedema, Immunoglobulin G, Conditional sentence, Polymyositis, Psoriasis, Disability, Lupus nephritis, ETH, Multiple sclerosis, Autoimmune hepatitis, BB Biotech, USD, Growth, Research, HIV disease progression rates, Histamine, Therapy, Swiss, Rheumatoid arthritis, ITP, Tissue, Patient, Swiss Federal Institute of Technology, Pharmaceutical industry, Vaccine

Autoimmunity is an area rich in scope for the delivery of innovative therapies by the biotech industry.

Key Points: 
  • Autoimmunity is an area rich in scope for the delivery of innovative therapies by the biotech industry.
  • Environmental factors, overactive immune responses, and genetic causes may be factors in triggering autoimmune disease.
  • At the end of September 2022, BB Biotech had achieved a paper gain of USD 277.6 mn on this investment.
  • Dr. Daniel Koller has been with Bellevue Asset Management since 2004 as a Portfolio Manager and was appointed Head of Investment Management Team BB Biotech AG in 2010.

ARCH Venture Partners Announces Patrick Weiss as Venture Partner

Retrieved on: 
Thursday, December 8, 2022
Publication, Organic chemistry, Swiss Federal Institute of Technology, Patrick, Federal Institute of Science and Technology, Lightspeed Venture Partners, Sirna, DNA, Swiss, ARCH, Twist, Twist Bioscience, Mentorship, Gene silencing, Economics, ETH, Qiagen, RNA, Dam, Fine chemical, Pharmaceutical industry

CHICAGO, Dec. 8, 2022 /PRNewswire/ -- ARCH Venture Partners, one of the world's leading early-stage technology venture firms, today announced the appointment of life sciences industry veteran Patrick Weiss as Venture Partner.

Key Points: 
  • CHICAGO, Dec. 8, 2022 /PRNewswire/ -- ARCH Venture Partners, one of the world's leading early-stage technology venture firms, today announced the appointment of life sciences industry veteran Patrick Weiss as Venture Partner.
  • "Building on nearly a decade of working with Patrick, we are extremely pleased to have him join the ARCH team.
  • Patrick will add further to those important capabilities," said ARCH Co-founder and Managing Director Keith Crandell.
  • ARCH Venture Partners invests in advanced technology companies and is one of the largest early-stage technology venture firms in the United States.

AltoVita Secures $9.5M Series A Investment to Redefine Corporate Accommodation Technology Across the Globe

Retrieved on: 
Monday, December 5, 2022
Professional Services, Technology, Software, Finance, Networks, Fintech, Internet, Travel, Former, Vivi, Housing, Lowe's, AMLA, CBRE, Government, Wall, Tate Modern, Toll Brothers, Starwood Capital Group, Marriott International, Partnership, Host Hotels & Resorts, UHNW, Novum, SME, JPMorgan Chase, BNP Paribas Real Estate, Multi-family office, Global 2000, Kimco Realty, City, The Related Companies, KPMG, Woman, Financial management, LP record, VC, Growth, News, Hewlett Packard Enterprise Networking, Cushman & Wakefield, MGM Resorts International, AUM, FINMA, SMBC, Quality control, Swiss Financial Market Supervisory Authority, Cryptocurrency, Management, Financial services, Bank, Lennar Corporation, Swiss

AltoVita has secured investment in a market which has seen less than 2% VC funding in 2022 going to businesses led by women.

Key Points: 
  • AltoVita has secured investment in a market which has seen less than 2% VC funding in 2022 going to businesses led by women.
  • Vivi Cahyadi Himmel, CEO and co-founder at AltoVita, commented: AltoVita is setting a new standard with a fresh, modern and agile approach when it comes to corporate accommodation technology.
  • The partnership with Fifth Wall will unlock immense real estate opportunities to provide unique inventories to meet our corporate demand globally.
  • Our recent investment will give AltoVita the firepower to scale its vision into new markets, and continue to develop its seamless solution for the fragmented corporate accommodation sector.